| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO And COO
2 companies
Chevallard Daniel R. is a CFO And COO at Viracta Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $179K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 26, 2022 | VIRX Viracta Therapeutics, Inc. | CFO And COO | Sale+OE | 3,596 | $1.90 | $6,836.36 | -4.3% | |
| Feb 28, 2022 | VIRX Viracta Therapeutics, Inc. | CFO And COO | Sale+OE | 3,998 | $2.78 | $11,112.44 | -5.0% | |
| Nov 29, 2021 | VIRX Viracta Therapeutics, Inc. | CFO And COO | Sale+OE | 7,579 | $4.81 | $36,463.76 | -4.8% |